Correction: Nishimura et al. Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut–Liver Axis and Epiregulin–IL-8-Associated Angiogenesis. Int. J. Mol. Sci. 2025, 26, 6710
International Journal of Molecular Sciences · 06.08.2026 · 27 (15) · 7041
DOI: 10.3390/ijms27157041 ↗Kurz gefasst
Korrektur in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.08.2026. Verfasst von Naoki Nishimura und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In the original publication [...]
Autor:innen und Institutionen
- Department of Gastroenterology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
- Medical Affairs Department, ASKA Pharmaceutical Co., Ltd., Minato-ku 108-8532, Tokyo, Japan.
ORCID-Profile: Norihisa Nishimura, Junichi Hanatani, Tatsuya Nakatani, Koh Kitagawa, Shinya Sato, Tadashi Namisaki
Zitieren
APA
Nishimura, N., Kaji, K., Nishimura, N., Hanatani, J., Nakatani, T., Oyama, M., Shibamoto, A., Tsuji, Y., Kitagawa, K., Sato, S., Namisaki, T., Tamaoki, S., & Yoshiji, H. (2026). Correction: Nishimura et al. Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut–Liver Axis and Epiregulin–IL-8-Associated Angiogenesis. Int. J. Mol. Sci. 2025, 26, 6710. International Journal of Molecular Sciences, 27(15), 7041. https://doi.org/10.3390/ijms27157041
Vancouver
Nishimura N, Kaji K, Nishimura N, Hanatani J, Nakatani T, Oyama M, et al. Correction: Nishimura et al. Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut–Liver Axis and Epiregulin–IL-8-Associated Angiogenesis. Int. J. Mol. Sci. 2025, 26, 6710. International Journal of Molecular Sciences. 2026;27(15):7041. doi:10.3390/ijms27157041
BibTeX
@article{Nishimura2026,
author = {Nishimura, Naoki and Kaji, Kosuke and Nishimura, Norihisa and Hanatani, Junichi and Nakatani, Tatsuya and Oyama, Masafumi and Shibamoto, Akihiko and Tsuji, Yuki and Kitagawa, Koh and Sato, Shinya and Namisaki, Tadashi and Tamaoki, Satoru and Yoshiji, Hitoshi},
title = {Correction: Nishimura et al. Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut–Liver Axis and Epiregulin–IL-8-Associated Angiogenesis. Int. J. Mol. Sci. 2025, 26, 6710},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {15},
pages = {7041},
doi = {10.3390/ijms27157041}
}
EUVIMED